201 related articles for article (PubMed ID: 32942023)
1. Curcumin: A therapeutic strategy for colorectal cancer?
Ruiz de Porras V; Layos L; Martínez-Balibrea E
Semin Cancer Biol; 2021 Aug; 73():321-330. PubMed ID: 32942023
[TBL] [Abstract][Full Text] [Related]
2. Curcumin functions as a MEK inhibitor to induce a synthetic lethal effect on KRAS mutant colorectal cancer cells receiving targeted drug regorafenib.
Wu CS; Wu SY; Chen HC; Chu CA; Tang HH; Liu HS; Hong YR; Huang CF; Huang GC; Su CL
J Nutr Biochem; 2019 Dec; 74():108227. PubMed ID: 31675556
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and Colorectal Cancer: From Basic to Clinical Evidences.
Pricci M; Girardi B; Giorgio F; Losurdo G; Ierardi E; Di Leo A
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235371
[TBL] [Abstract][Full Text] [Related]
4. Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer.
Jalili-Nik M; Soltani A; Moussavi S; Ghayour-Mobarhan M; Ferns GA; Hassanian SM; Avan A
J Cell Physiol; 2018 Sep; 233(9):6337-6345. PubMed ID: 29219177
[TBL] [Abstract][Full Text] [Related]
5. Dietary phenolics against colorectal cancer--From promising preclinical results to poor translation into clinical trials: Pitfalls and future needs.
Núñez-Sánchez MA; González-Sarrías A; Romo-Vaquero M; García-Villalba R; Selma MV; Tomás-Barberán FA; García-Conesa MT; Espín JC
Mol Nutr Food Res; 2015 Jul; 59(7):1274-91. PubMed ID: 25693744
[TBL] [Abstract][Full Text] [Related]
6. Curcuma as an adjuvant in colorectal cancer treatment.
Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
[TBL] [Abstract][Full Text] [Related]
7. The Potential Clinical Value of Curcumin and its Derivatives in Colorectal Cancer.
Yao Z; Le TH; Du Q; Mu H; Liu C; Zhu Y
Anticancer Agents Med Chem; 2021; 21(13):1626-1637. PubMed ID: 33191888
[TBL] [Abstract][Full Text] [Related]
8. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
[TBL] [Abstract][Full Text] [Related]
10. Curcumin and colorectal cancer: An update and current perspective on this natural medicine.
Weng W; Goel A
Semin Cancer Biol; 2022 May; 80():73-86. PubMed ID: 32088363
[TBL] [Abstract][Full Text] [Related]
11. Curcumin cytotoxicity is enhanced by PTEN disruption in colorectal cancer cells.
Chen L; Li WF; Wang HX; Zhao HN; Tang JJ; Wu CJ; Lu LT; Liao WQ; Lu XC
World J Gastroenterol; 2013 Oct; 19(40):6814-24. PubMed ID: 24187456
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and Derivatives in Nanoformulations with Therapeutic Potential on Colorectal Cancer.
Idoudi S; Bedhiafi T; Hijji YM; Billa N
AAPS PharmSciTech; 2022 Apr; 23(5):115. PubMed ID: 35441267
[TBL] [Abstract][Full Text] [Related]
13. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Bar-Sela G; Epelbaum R; Schaffer M
Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
[TBL] [Abstract][Full Text] [Related]
14. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.
Irving GR; Iwuji CO; Morgan B; Berry DP; Steward WP; Thomas A; Brown K; Howells LM
Trials; 2015 Mar; 16():110. PubMed ID: 25872567
[TBL] [Abstract][Full Text] [Related]
15. Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer.
Shafiee M; Mohamadzade E; ShahidSales S; Khakpouri S; Maftouh M; Parizadeh SA; Hasanian SM; Avan A
Curr Pharm Des; 2017; 23(13):2002-2008. PubMed ID: 28117012
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer.
Ismail NI; Othman I; Abas F; H Lajis N; Naidu R
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108984
[TBL] [Abstract][Full Text] [Related]
17. Phytosomal curcumin inhibits tumor growth in colitis-associated colorectal cancer.
Marjaneh RM; Rahmani F; Hassanian SM; Rezaei N; Hashemzehi M; Bahrami A; Ariakia F; Fiuji H; Sahebkar A; Avan A; Khazaei M
J Cell Physiol; 2018 Oct; 233(10):6785-6798. PubMed ID: 29737515
[TBL] [Abstract][Full Text] [Related]
18. Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer.
Giladi N; Kazanov D; Shpitz B; Aroch I; Kraus S; Arber N
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S117-24. PubMed ID: 20374023
[TBL] [Abstract][Full Text] [Related]
19. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
Megna BW; Carney PR; Depke MG; Nukaya M; McNally J; Larsen L; Rosengren RJ; Kennedy GD
J Surg Res; 2017 Jun; 213():16-24. PubMed ID: 28601309
[TBL] [Abstract][Full Text] [Related]
20. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
Mbese Z; Khwaza V; Aderibigbe BA
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
